Stay updated on Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.

Latest updates to the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new site revision, v3.5.4, was added to the history, replacing the previous revision v3.5.3 and signaling an update to the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA newer record version was added, indicating administrative updates to the study’s status and associated contacts/locations. The only other textual change is an internal version/revision label for the ClinicalTrials.gov interface.SummaryDifference0.4%

- Check47 days agoChange DetectedAdded revision: v3.5.2 to the history and deleted revision: v3.5.0 from the history.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision v3.5.0 has been added to the record history. Revision v3.4.3 has been removed from the record history.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the history.SummaryDifference0.1%

- Check111 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the prior government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fianlimab & Cemiplimab Combo in Melanoma Clinical Trial page.